APDNAPPLIED DNA SCIENCES INC

Nasdaq adnas.com


$ 3.51 $ -0.29 (-7.75 %)    

Friday, 10-May-2024 15:44:53 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 3.45
$ 3.98
$ 3.45 x 200
$ 3.52 x 200
$ 3.21 - $ 4.63
$ 3.11 - $ 37.20
1,427,037
na
3.01M
$ 0.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-08-2024 12-31-2023 10-Q
3 12-07-2023 09-30-2023 10-K
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-09-2023 12-31-2022 10-Q
7 12-14-2022 09-30-2022 10-K
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-Q
11 12-09-2021 09-30-2021 10-K
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-Q
15 12-17-2020 09-30-2020 10-K
16 08-06-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-Q
19 12-12-2019 09-30-2019 10-K
20 08-13-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-Q
23 12-18-2018 09-30-2018 10-K
24 08-13-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-Q
27 12-28-2017 09-30-2017 10-K
28 08-10-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-Q
31 12-06-2016 09-30-2016 10-K
32 08-11-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 02-10-2016 12-31-2015 10-Q
35 12-14-2015 09-30-2015 10-K
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 02-09-2015 12-31-2014 10-Q
39 12-15-2014 09-30-2014 10-K
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 applied-dna-sciences-q2-eps-531-misses-450-estimate-sales-92963k-miss-95000k-estimate

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(5.31) per share which missed the analyst consensus estimate o...

 applied-dna-announces-1-for-20-reverse-stock-split--will-begin-trading-on-a-split-adjusted-basis-commencing-upon-market-open-on-thursday-april-25-2024

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced ...

 hc-wainwright--co-maintains-buy-on-applied-dna-sciences-adjusts-price-target-to-15

HC Wainwright & Co. analyst Yi Chen maintains Applied DNA Sciences (NASDAQ:APDN) with a Buy, adjusts target to $1.5 from...

 applied-dna-sciences-q1-2024-gaap-eps-009-beats-031-estimate-sales-89116k-beat-77600k-estimate

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 applied-dna-announces-joint-development-agreement-to-integrate-linea-ivt-platform-into-cdmo-kudo-biotechnologys-mrna-manufacturing-workflow

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability wit...

 lululemon-to-rally-around-14-here-are-10-top-analyst-forecasts-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION